Circulating markers of inflammation and endothelial function, and their relationship to diabetic retinopathy

To examine the relationships of serum markers of inflammation and endothelial function to diabetic retinopathy.

[1]  P. Connell,et al.  Circulating biomarkers of diabetic retinopathy: a systematic review and meta-analysis , 2012 .

[2]  T. Wong,et al.  Are obesity and anthropometry risk factors for diabetic retinopathy? The diabetes management project. , 2011, Investigative ophthalmology & visual science.

[3]  J. Shaw,et al.  Diabetic Retinopathy Is Related to Both Endothelium-Dependent and -Independent Responses of Skin Microvascular Flow , 2011, Diabetes Care.

[4]  J. Shaw,et al.  Serum Apolipoprotein AI and B Are Stronger Biomarkers of Diabetic Retinopathy Than Traditional Lipids , 2011, Diabetes Care.

[5]  P. Mitchell,et al.  C-reactive protein, body mass index, and diabetic retinopathy. , 2010, Investigative ophthalmology & visual science.

[6]  F. Greenway,et al.  Obesity Increases the Production of Proinflammatory Mediators from Adipose Tissue T Cells and Compromises TCR Repertoire Diversity: Implications for Systemic Inflammation and Insulin Resistance , 2010, The Journal of Immunology.

[7]  R. Klein,et al.  The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: Wisconsin epidemiologic study of diabetic retinopathy. , 2009, Archives of ophthalmology.

[8]  R. Klein,et al.  Inflammatory, Hemostatic, and Other Novel Biomarkers for Diabetic Retinopathy , 2009, Diabetes Care.

[9]  T. Curtis,et al.  Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis? , 2009, Eye.

[10]  H. Parving,et al.  Endothelial dysfunction and low‐grade inflammation and the progression of retinopathy in Type 2 diabetes , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[11]  E. Agrón,et al.  Serum inflammatory markers in diabetic retinopathy. , 2005, Investigative ophthalmology & visual science.

[12]  C. D. A. Stehouwer,et al.  Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study , 2005, Diabetologia.

[13]  N. Chaturvedi,et al.  Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes—the EURODIAB Prospective Complications Study , 2005, Diabetologia.

[14]  Mark B Pepys,et al.  C-reactive protein: a critical update. , 2003, The Journal of clinical investigation.

[15]  R. Hornero,et al.  Retinal image analysis to detect and quantify lesions associated with diabetic retinopathy , 2003, The 26th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[16]  J. Schneider,et al.  Elevated plasma endothelin-1 levels in diabetes mellitus. , 2002, American journal of hypertension.

[17]  L. Bouter,et al.  Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study. , 2002, Diabetes care.

[18]  T. Sugiyama,et al.  POSSIBLE INVOLVEMENT OF ENDOTHELIN–1 AND NITRIC OXIDE IN THE PATHOGENESIS OF PROLIFERATIVE DIABETIC RETINOPATHY , 2001, Retina.

[19]  P. Ridker,et al.  Novel clinical markers of vascular wall inflammation. , 2001, Circulation research.

[20]  H. Brenner,et al.  Association between C-reactive protein and features of the metabolic syndrome: a population-based study. , 2000, Diabetes care.

[21]  L. Aiello,et al.  Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[22]  A. Somogyi,et al.  Role of endothelin-1 in diabetes mellitus. , 1998, Diabetes/metabolism reviews.

[23]  J. Olson,et al.  Soluble leucocyte adhesion molecules in diabetic retinopathy stimulate retinal capillary endothelial cell migration , 1997, Diabetologia.

[24]  P. Libby,et al.  Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma. , 1993, The American journal of pathology.

[25]  N. Iwasaki,et al.  Increased Plasma Endothelin in NIDDM Patients With Retinopathy , 1992, Diabetes Care.

[26]  T. Lüscher,et al.  Nitric oxide and endothelin-1 are important regulators of human ophthalmic artery. , 1992, Investigative ophthalmology & visual science.

[27]  R. Ross,et al.  Studies of Hypercholesterolemia in the Nonhuman Primate: II. Fatty Streak Conversion to Fibrous Plaque , 1984, Arteriosclerosis.

[28]  R. Ross,et al.  Studies of Hypercholesterolemia in the Nonhuman Primate: I. Changes that Lead to Fatty Streak Formation , 1984, Arteriosclerosis.

[29]  T. Minamino,et al.  Adipose tissue inflammation in diabetes and heart failure. , 2013, Microbes and infection.

[30]  B Kirchhof,et al.  Leukocyte-mediated endothelial cell injury and death in the diabetic retina. , 2001, The American journal of pathology.

[31]  T. Sano,et al.  [Diabetic retinopathy]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.

[32]  K. Flegal,et al.  Assessing obesity: classification and epidemiology. , 1997, British medical bulletin.